Abel Hall LLC’s AstraZeneca AZN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $381K | Sell |
5,456
-795
| -13% | -$55.6K | 0.18% | 118 |
|
|
2025
Q1 | $459K | Buy |
6,251
+1,800
| +40% | +$132K | 0.28% | 58 |
|
|
2024
Q4 | $292K | Sell |
4,451
-32
| -0.7% | -$2.1K | 0.19% | 92 |
|
|
2024
Q3 | $349K | Sell |
4,483
-130
| -3% | -$10.1K | 0.23% | 77 |
|
|
2024
Q2 | $360K | Buy |
4,613
+777
| +20% | +$60.6K | 0.25% | 65 |
|
|
2024
Q1 | $260K | Buy |
3,836
+153
| +4% | +$10.4K | 0.19% | 94 |
|
|
2023
Q4 | $248K | Buy |
+3,683
| New | +$248K | 0.21% | 86 |
|